|
COX4NB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.647680E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.875680E-03 |
| Normal-vs-Stage2 |
6.503700E-02 |
| Normal-vs-Stage3 |
4.88740000004206E-06 |
| Normal-vs-Stage4 |
4.897600E-02 |
| Stage1-vs-Stage2 |
8.185000E-01 |
| Stage1-vs-Stage3 |
3.642300E-02 |
| Stage1-vs-Stage4 |
7.413000E-01 |
| Stage2-vs-Stage3 |
8.530100E-02 |
| Stage2-vs-Stage4 |
9.623600E-01 |
| Stage3-vs-Stage4 |
6.541500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54737999999988E-05 |
| Normal-vs-AfricanAmerican |
3.038600E-01 |
| Normal-vs-Asian |
3.551200E-01 |
| Caucasian-vs-AfricanAmerican |
4.83100000003844E-06 |
| Caucasian-vs-Asian |
6.038800E-01 |
| AfricanAmerican-vs-Asian |
3.021000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.71050000003148E-06 |
| Normal-vs-Female |
8.356100E-02 |
| Male-vs-Female |
2.578000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.176420E-01 |
| Normal-vs-Age(41-60Yrs) |
3.784900E-03 |
| Normal-vs-Age(61-80Yrs) |
8.3399000000095E-05 |
| Normal-vs-Age(81-100Yrs) |
2.987900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.295200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.852800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.356000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.810800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.447400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.064800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.275200E-01 |
| Normal-vs-Grade 2 |
3.379300E-04 |
| Normal-vs-Grade 3 |
1.360870E-04 |
| Normal-vs-Grade 4 |
2.132300E-02 |
| Grade 1-vs-Grade 2 |
1.752590E-01 |
| Grade 1-vs-Grade 3 |
5.816200E-02 |
| Grade 1-vs-Grade 4 |
1.404030E-01 |
| Grade 2-vs-Grade 3 |
5.157600E-01 |
| Grade 2-vs-Grade 4 |
7.587800E-01 |
| Grade 3-vs-Grade 4 |
4.858000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.08979999999959E-05 |
| Normal-vs-ccB subtype |
1.482240E-03 |
| ccA subtype-vs-ccB subtype |
4.518800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.376200E-04 |
| Normal-vs-N1 |
2.883200E-01 |
| N0-vs-N1 |
6.049600E-01 |
|
|
